Dicot AB

DICOT · ST · Healthcare / Drug Manufacturers - Specialty & Generic

0.2176SEK+0.00 (+0.83%)

Price History

Full chart

Market Stats

Previous Close0.2158

Open0.215

Day Range0.21 – 0.218

52-Week Range0.175 – 1.18

Volume4.11M

Market Cap767.97M

P/E (TTM)0.00

Forward P/E0.00

EPS-0.03

Dividend Yield0.00%

Beta0.88

50-Day Avg0.2187

200-Day Avg0.2739

About

Dicot Pharma AB engages in the development of pharmaceutical products in Sweden. It develops LIB-01 that is in Phase 2a clinical trial for the treatment of erectile dysfunction and under medical discovery for treating premature ejaculation. The company was formerly known as Dicot AB (publ) and changed its name to Dicot Pharma AB in May 2024. Dicot Pharma AB was incorporated in 2015 and is based in Uppsala, Sweden.

Company Details

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOMs. Elin Trampe
Employees4
HeadquartersS:t Olofsgatan 11A, Uppsala, Sweden, 753 21, Sweden
Websitehttps://www.dicotpharma.com

Leadership

Ms. Elin TrampeChief Executive Officer · b. 1980
Dr. Jarl Wikberg Ph.D.Founder
Ms. Cecilia DrivingChief Financial Officer · b. 1971
Dr. Mats Silvander Ph.D.Chief Technical Officer
Ms. Charlotta GauffinChief Scientific Officer · b. 1971
Mr. Hakan WickholmChief Business Officer · b. 1959

Financials

Income Statement

Currency: SEK	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	0	0	0	0	0
Operating Income	-27.25M	-31.80M	-45.03M	-59.28M	-82.62M
EBITDA	-	-31.72M	-44.08M	-57.68M	-80.23M
Net Income	-27.17M	-31.76M	-44.16M	-57.70M	-80.23M
Interest Expense	3.87K	33.08K	66.00K	10.00K	6.00K

Balance Sheet

Currency: SEK	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	31.77M	12.37M	53.55M	123.62M	85.46M
Total Liabilities	3.42M	7.01M	9.16M	11.96M	12.11M
Total Equity	28.35M	5.36M	44.39M	111.67M	73.36M
Cash	30.33M	9.38M	47.34M	113.42M	69.19M

Cash Flow

Currency: SEK	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-25.87M	-29.71M	-45.23M	-58.87M	-85.85M
Capital Expenditure	0	0	0	0	0
Free Cash Flow	-25.87M	-29.71M	-45.23M	-58.87M	-85.85M
FCF to OCF	100.00%	100.00%	100.00%	100.00%	100.00%

Earnings

Report Date	Sep 30, 2018	Dec 31, 2018	Mar 31, 2019	Jun 30, 2019	Sep 30, 2019	Dec 31, 2019	Mar 31, 2020	Jun 30, 2020	Sep 30, 2020	Dec 31, 2020	Mar 31, 2021	Jun 30, 2021	Sep 30, 2021	Dec 31, 2021	Mar 31, 2022	Jun 30, 2022
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	-0.09	-0.27	-0.31	-0.22	-0.33	-0.17	-0.32	-0.17	-0.09	-0.10	-0.18	-0.08	-0.07	-0.10	-0.09	-0.08
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap767.97M

Enterprise Value538.99M

Trailing P/E0.00

Forward P/E0.00

Price / Sales1778.65

Price / Book3.08

EPS-0.03

Book Value0.074

Revenue (TTM)0

Gross Profit (TTM)0

EBITDA-82.62M

Profit Margin0.00%

Operating Margin-18700.00%

Return on Equity-36.63%

Return on Assets-22.18%

Shares Outstanding3.47B

Shares Float3.19B

Beta0.88

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%